Sonoma Pharmaceuticals, Inc (SNOA)

Etorro trading 970x250
Sonoma Pharmaceuticals, Inc (SNOA) Logo

About Sonoma Pharmaceuticals, Inc

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, a hypochlorous acid (HOCl) based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a product indicated to promote healing through the management of new and old scars resulting from surgical procedures and trauma wounds or burns; SebuDerm, a product indicated to manage and relieve the burning, itching, pain, and distraction associated with seborrhea and seborrheic dermatitis; and Ceramax, a Lipogrid based skin barrier cream for management of dry itchy skin, minor skin irritations, rashes, and inflammation caused by various skin conditions, as well as Loyon for the management of skin scaling. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a line of products designed to stimulate expedited healing by targeting various pathogens, as well as antibiotic-resistant strains that slow natural healing of wounds. In addition, the company offers MicrocynAH and MicrocynVS, which are HOCl-based solutions designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Pediacyn, Epicyn, Gramaderm, and Microdacyn for dermatoses, scar management, and acne; and Sinudox for nasal irrigation, including moistening of cuts, abrasions, and lacerations located in the nasal cavity. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia. Address: 645 Molly Lane, Woodstock, GA, United States, 30102

Sonoma Pharmaceuticals, Inc News and around…

Latest news about Sonoma Pharmaceuticals, Inc (SNOA) common stock and company :

Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.
03 May, 2022 Yahoo! Finance

WOODSTOCK, Ga., May 03, 2022--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions and disinfectant use, and its partner, the MicroSafe Group DMCC, received EPA approval for Nanocyn® as a hospital-grade disinfectant in the United States. Nanocyn®, which is manufactured by

Sonoma Pharma Launches New Urinary Tract Infection Product In New Zealand, Australia, South Africa
30 Mar, 2022 Yahoo! Finance

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) has launched Microdox, an urinary tract infection catheter and bladder rinse in New Zealand, Australia, and South Africa. Microdox is a super-oxidized solution based on Sonoma's patented Microcyn Technology intended to treat and prevent infections in the urinary tract and bladder. Microdox is a non-irritating and non-toxic solution and is ready for immediate use. It is currently available through Sonoma's partners, Te Arai BioFarma in New Zealand and Aus

Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa
30 Mar, 2022 Yahoo! Finance

WOODSTOCK, Ga., March 30, 2022--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, and dermatological conditions, today announced that it has launched Microdox®, an urinary tract infection catheter and bladder rinse in New Zealand, Australia and South Africa.

Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results
11 Feb, 2022 Yahoo! Finance

WOODSTOCK, Ga., February 11, 2022--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions today announced financial results for its third fiscal quarter and nine months ended December 31, 2021.

HBC Financial Services, PLLC Buys Apollo Investment Corp, Lockheed Martin Corp, Airbnb Inc, ...
28 Jan, 2022 Yahoo! Finance

Investment company HBC Financial Services, PLLC (Current Portfolio) buys Apollo Investment Corp, Lockheed Martin Corp, Airbnb Inc, Deere, Sonoma Pharmaceuticals Inc, sells Apple Inc, Lowe's Inc, PayPal Holdings Inc, Waste Management Inc, Cleanspark Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, HBC Financial Services, PLLC.

Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China
20 Jan, 2022 Yahoo! Finance

WOODSTOCK, Ga., January 20, 2022--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has added Salus Medical as an additional distribution partner in the United States for dental care and expanded its oral and dental care li

Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022
05 Jan, 2022 Yahoo! Finance

WOODSTOCK, Ga., January 05, 2022--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions, today announced that it will be featured as a presenting company at the H.C. Wainwright BioConnect Conference. The conference is being held on January 10-13, 2022 virtually.

Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results
15 Nov, 2021 Yahoo! Finance

WOODSTOCK, Ga., November 15, 2021--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions today announced financial results for its second fiscal quarter and six months ended September 30, 2021.

Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast Asia
09 Nov, 2021 Yahoo! Finance

WOODSTOCK, Ga., November 09, 2021--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions and disinfectant use, and its long-time partner, Dyamed Biotech Pte Ltd., announce a renewed and expanded long-term partnership for Singapore, Malaysia, Indonesia and Thailand for multiple indications using S

The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
15 Oct, 2021 Yahoo! Finance

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of Moderna's COVID-19 Vaccine Booster Shot For Use In Select Population Moderna, Inc. (NASDAQ: MRNA) confirmed the U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee recommended that the FDA grant an emergency use authorization for a booster dose of its COVID-19 vaccine at the 50 µg dose level for people aged 65 and older; people

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill Time
15 Oct, 2021 Yahoo! Finance

WOODSTOCK, Ga., October 15, 2021--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions and disinfectant use, and its partner, the MicroSafe Group, announce that the Australian Therapeutic Goods Administration (TGA) has approved extended claims for Nanocyn® Disinfectant and Sanitizer, which is ma

Sonoma Pharmaceuticals (NASDAQ:SNOA) Has Debt But No Earnings; Should You Worry?
30 Sep, 2021 Yahoo! Finance

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

48 Biggest Movers From Yesterday
29 Sep, 2021 Yahoo! Finance

Gainers Gogo Inc. (NASDAQ: GOGO) shares climbed 37.6% to close at $16.82 on Tuesday after the company raised the long-term financial targets announced during Q4 2020 earnings. Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) climbed 30.7% to close at $6.99 on Tuesday after the company announced the OTC consumer launch of Regenacyn Advanced Scar Gel and Ocucyn Eyelid & Eyelash Cleanser on Amazon.com and MucoClyns on Amazon sites in Europe. DatChat, Inc. (NASDAQ: DATS) gained 26.7% to close at $14.61.

Mid-Afternoon Market Update: Dow Tumbles 500 Points; Sonoma Pharmaceuticals Shares Spike Higher
28 Sep, 2021 Yahoo! Finance

Toward the end of trading Tuesday, the Dow traded down 1.45% to 34,363.18 while the NASDAQ fell 2.54% to 14,590.40. The S&P also fell, dropping 1.82% to 4,362.34. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 43,116,440 cases with around 690,430 deaths. India confirmed a total of at least 33,697,580 cases and 447,370 deaths, while Brazil reported over 21,366,390 COVID-19 cases with 594,650 deaths. In total, there were at least 232,407,580 case

Mid-Day Market Update: Nasdaq Down 2.5%; IHS Markit Posts Upbeat Earnings
28 Sep, 2021 Yahoo! Finance

Midway through trading Tuesday, the Dow traded down 1.38% to 34,389.17 while the NASDAQ fell 2.58% to 14,583.28. The S&P also fell, dropping 1.89% to 4,359.24. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 43,116,440 cases with around 690,430 deaths. India confirmed a total of at least 33,697,580 cases and 447,370 deaths, while Brazil reported over 21,366,390 COVID-19 cases with 594,650 deaths. In total, there were at least 232,407,580 cases o

Sonoma Pharmaceuticals Launches Its First Over-the-Counter Products in the U.S. on Amazon and a New Consumer-Focused Product on Amazon in Europe
28 Sep, 2021 Yahoo! Finance

WOODSTOCK, Ga., September 28, 2021--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter ("OTC") consumer launch of Regenacyn® Advanced Scar Gel and Ocucyn® Eyelid & Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three prod

Why Sonoma Pharmaceuticals Shares Are Trading Lower Today
20 Aug, 2021 Yahoo! Finance

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) is trading significantly lower Friday amid possible profit taking after the stock surged Thursday following the company's launch of two new dental products. Sonoma Pharmaceuticals launched OroGenix Oral Hygiene Rinse, which was developed with Gabriel Science and is the company's second dental product in the U.S. OroGenix Oral Hygiene Rinse uses Sonoma’s patented Microcyn technology to cleanse teeth, gums, and mouth. Sonoma and Medical Systems Solutions a

Why Sonoma Pharmaceuticals Shares Are Surging Higher Today
19 Aug, 2021 Yahoo! Finance

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) is surging higher Thursday after the company announced it launched two new dental products. Sonoma Pharmaceuticals launched OroGenix Oral Hygiene Rinse, which was developed with Gabriel Science and is the company's second dental product in the U.S. OroGenix Oral Hygiene Rinse uses Sonoma’s patented Microcyn technology to cleanse teeth, gums, and mouth. Sonoma and Medical Systems Solutions also launched Microdacyn Oral Care for both professional and consu

Why Sonoma Pharma (SNOA) Stock Skyrocketing On Thursday
19 Aug, 2021 Yahoo! Finance

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) stock doubled in reaction to the launch of two new dental products. OroGenix Oral Hygiene Rinse is Sonoma's second dental product in the U.S. and was developed with its partner Gabriel Science LLC. Additionally, Sonoma and its partner, Medical Systems Solutions, have launched Microdacyn Oral Care for professional and consumer use in Switzerland. After launching Endocyn for root canal irrigation in December 2020, Sonoma's second dental product in the U.S.

5 Top Stock Gainers for Thursday: Macy's, Nvidia, Sonoma Pharma and Kohl's
19 Aug, 2021 Yahoo! Finance

Sonoma Pharmaceuticals, Macy's, Kohl's, Bath & Body Works and Nvidia are five top gainers for Thursday.

Sonoma Pharmaceuticals, Inc (SNOA) is a NASDAQ Common Stock listed in , ,

970x250